Advanced Liver Therapies (ALT) at Baylor St. Luke’s Medical Center is a clinical research center for liver diseases affiliated with the Baylor College of Medicine. The mission is to conduct Food & Drug Administration (FDA) approved clinical studies designed to advance the science and practice of hepatology and liver transplantation. With over 75 years of combined research experience, our staff endorses and practices the highest standards of ethical research, while providing opportunities for all patients to participate in clinical trials.

Advanced Liver Therapies provides studies for new therapies of liver disease and complications associated with those diseases. We conduct studies for a variety of liver diseases:

  • Hepatitis C
  • Hepatitis B
  • Fatty Liver Disease (NAFLD/NASH)
  • Hepatic Encephalopathy
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
  • Hepatorenal Syndrome
  • Anti-Fibrosis
  • Cirrhosis

Helpful Resources
CHI St. Luke's Health Liver Health Outreach (our community outreach and education partner) provides an avenue for community access to information about treatment options including our studies. Please visit the Liver Health Outreach program website for more information about the program and free screenings for hepatitis B and hepatitis C.

For more information on liver disease, please visit www.texasliver.org.

For further studies and information on clinical trials, please visit www.clinicaltrials.gov.

Contact Us
Research Office: 832-355-8966
E-mail: liverresearch@stlukeshealth.org

6620 Main Street, Suite 1505
Houston, Texas 77030

Phone calls and emails seeking information about liver disease and our studies are always welcomed. Please include your phone number and email address. A member of our research team will contact you.